CLSD Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CLSD shares is 58, representing 23.17% of the company's common stock.

TOWER RESEARCH CAPITAL LLC (TRC), in the last quarter, reduced its stake in CLSD by -43.64% restricting it's holding to 7.9 thousand shares of worth nearly $12.08K. SIMPLEX TRADING, LLC also lessened -53.62% of the CLSD shares from its portfolio, reducing its holding to 5.33 thousand shares of worth $8.00K. BLACKROCK INC. also shunned CLSD shares holding by -0.2% last quarter which brought its holding to 758.23 thousand shares worth $1.16M.

As per its latest 13F filing, VANGUARD GROUP INC increased its stake in CLSD by 14.45% in the last quarter. The institutional holder raised its holding to 2.49 million shares having worth more than $3.81M. MILLENNIUM MANAGEMENT LLC also added 515.16% more shares of CLSD to its portfolio, raising its holding to 206.93 thousand shares of worth $316.60K. JANE STREET GROUP, LLC also increased its CLSD shares holding by 100% which brought its holding to 176.71 thousand shares worth $270.36K.

The insider with the most stakes in CLSD is White Daniel H. , President and CEO at the company. Additionally, CLSD stock is highly held by CEO LASEZKAY GEORGE M and 10 percent owner WHITMORE BRADFORD T among others.

Company executives, directors, and other insiders own 7.39% percent of Clearside Biomedical, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which CLSD insiders have sold stock, totaling 0 shares. Insiders that have sold shares include DEIGNAN CHARLES A., LASEZKAY GEORGE M, and CIULLA THOMAS.

There have been 1 transaction(s) during the past 6-months in which Clearside Biomedical, Inc. insiders have bought stock, totalling 36500 shares

Around 100K Clearside Biomedical, Inc. shares are held by insiders, which represents about 7.39% of CLSD stock.

CLSD President and CEO, White Daniel H. holds the largest portfolio of the company's shares. CLSD shares owned by White total nearly 483.34 thousand.

TOWER RESEARCH CAPITAL LLC (TRC) is the largest institutional owner in CLSD which holds 7.9 thousand shares worth $12.08K or 0.01% of the total CLSD shares outstanding followed by VANGUARD GROUP INC with ownership of 2.49 million shares representing 4.03% of the CLSD ownership. MILLENNIUM MANAGEMENT LLC is the third largest stakeholder with 206.93 thousand shares or 0.33% of the ownership worth more than $316.60K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CLSD is concerned, it is a stock which is optionable.

Number of CLSD shares short is 1.76M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 75.84M shares of CLSD are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CLSD has 69.12M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CLSD is 1.21.